ClavystBio is a life sciences venture investor set up by Temasek. Our mission is to accelerate the commercialization of life sciences breakthroughs into health impact. We invest and partner with innovators, entrepreneurs and founders to launch and grow global companies in Singapore. We foster partnerships among academics, industry and investors, and convene life sciences communities at our collaborative innovation space Node 1. Together, we advance Singapore as a global life sciences translational hub. Since our inception in 2022, ClavystBio has committed over US$220m to biotech, diagnostics and digital health companies, as well as early-stage VC funds.